The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2016 / Mar / Ready to Break the Mold?
Manufacture Drug Delivery Regulation & Standards Business & Trends Facilities & Equipment Technology & Manufacturing Sponsored

Ready to Break the Mold?

Pharma suppliers are teaming up to take ready-to-use technology to the next level.

03/22/2016 1 min read

Sponsored By

Share

Articles:

Collaborate to Innovate By Charlotte Barker Are You Ready? With Gregor Deutschle and Markus Hörsch A Seamless Fit With Nigel Ware and Mike Schaefers A Study in Collaboration With Johannes Selch Crystal Clear Insight Reporting from the “Insight Forum for Ready-To-Use Solutions in Aseptic Manufacturing” The Road Less Traveled Sitting Down With… Andreas Reisse

Download the pdf here

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Prula-cel Shows Early Promise in Lupus
Drug Delivery Cell & Gene Industry News
Prula-cel Shows Early Promise in Lupus

October 8, 2026

2 min read

Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy

In Vivo CAR T: A New Route to Treating Autoimmune Disease
Cell & Gene Drug Delivery Development & Clinical
In Vivo CAR T: A New Route to Treating Autoimmune Disease

July 13, 2026

6 min read

How targeted in vivo CAR T delivery could pave the way for autoimmune disease treatments

The New Path to ADCs
Biopharma Drug Delivery Drug Discovery
The New Path to ADCs

March 24, 2026

9 min read

Engineering payload selectivity for a better quality of life

Building an Integrated Discovery Engine
Future of Pharma Drug Delivery Interviews
Building an Integrated Discovery Engine

February 23, 2026

4 min read

An Interview with Adam Davenport, CSO, Concept Life Sciences

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: